Glycosylation of tissue factor is not essential for its transport or functions

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 8, 2011, Pages 1511-1520

  Kothari, H ^a   Rao, L Vijaya Mohan ^a   Pendurthi, U R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Factor VIIa; Factor X; Glycosylation; Tissue factor

Indexed keywords

BETA ACTIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; GLYCAN DERIVATIVE; IODINE 125; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; MUTANT PROTEIN; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN; TUNICAMYCIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CLOTTING; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WILD TYPE;

ANIMALS; BLOOD COAGULATION; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FACTOR XA; GLYCOSYLATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTOR, PAR-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; TUNICAMYCIN;

EID: 80051599453     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04332.x     Document Type: Article

References (31)

1. Rao LVM, Pendurthi UR. Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol 2005; 25: 47-56.
2. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 2005; 25: 1545-50.
3. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-22.
4. Egorina EM, Sovershaev MA, Osterud B. Regulation of tissue factor procoagulant activity by post-translational modifications. Thromb Res 2008; 122: 831-7.
5. Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell 2006; 126: 855-67.
6. Paborsky LR, Harris RJ. Post-translational modifications of recombinant human tissue factor. Thromb Res 1990; 60: 367-76.
7. Pitlick FA. Concanavalin A inhibits tissue factor coagulant activity. J Clin Invest 1975; 55: 175-9.
8. Goldstein IJ, Hollerman CE, Smith EE. Protein-carbohydrate interaction. II. Inhibition studies on the interaction of concanavalin A with polysaccharides. Biochemistry 1965; 4: 876-83.
9. Shands JW Jr. Macrophage factor X activator formation: metabolic requirements for synthesis of components. Blood 1985; 65: 169-75.
10. Bona R, Lee E, Rickles F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 1987; 48: 487-500.
11. Paborsky LR, Tate KM, Harris RJ, Yansura DG, Band L, McCray G, Gorman CM, O'Brien DP, Chang JY, Swartz JR, Fung VP, Thomas JN, Vehar GA. Purification of recombinant human tissue factor. Biochemistry 1989; 28: 8072-7.
12. Stone MJ, Ruf W, Miles DJ, Edgington TS, Wright PE. Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J 1995; 310: 605-14.
13. Krudysz-Amblo J, Jennings ME, Mann KG, Butenas S. Carbohydrates and activity of natural and recombinant tissue factor. J Biol Chem 2010; 285: 3371-82.
14. Rehemtulla A, Ruf W, Edgington TS. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem 1991; 266: 10294-9.
15. Kothari H, Nayak RC, Rao LV, Pendurthi UR. Cystine186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption. Blood 2010; 115: 4273-83.
16. Pendurthi UR, Ghosh S, Mandal SK, Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood 2007; 110: 3900-8.
17. Almus FE, Rao LVM, Pendurthi UR, Quattrochi L, Rapaport SI. Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin. Blood 1991; 77: 1256-62.
18. Mandal SK, Pendurthi UR, Rao LVM. Cellular localization and trafficking of tissue factor. Blood 2006; 107: 4746-53.
19. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Rao LV. Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem 2007; 282: 11849-57.
20. Rao LVM. Characterization of anti-tissue factor antibody and its use in immunoaffinity purification of human tissue factor. Thromb Res 1988; 51: 373-84.
21. Morrissey JH, Fair DS, Edgington TS. Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res 1988; 52: 247-61.
22. Rao LVM, Pendurthi UR. Tissue factor on cells. Blood Coagul Fibrinolysis 1998; 9: S27-35.
23. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26: 456-61.
24. Sen P, Gopalakrishnan R, Kothari H, Keshava S, Clark CA, Esmon CT, Pendurthi UR, Rao LV. Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection. Blood 2011; 117: 3199-208.
25. Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, Felding-habermann B, Takada Y, Mueller BM, Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008; 111: 190-9.
26. Hart GW. Glycosylation. Curr Opin Cell Biol 1992; 4: 1017-23.
27. van den Besselaar AMHP, Bertina RM. Interaction of thromboplastin apoprotein of different tissues with concanavalin A- evidence for heterogeneous glycosylation of the human apoprotein. Thromb Haemost 1984; 52: 192-5.
28. Spicer EK, Horton R, Bloem L, Back R, Williams KR, Guha A, Kraus J, Lin TC, Nemerson Y, Konigsberg WH. Isolation of cDNA clones for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A 1987; 84: 5148-52.
29. Scarpati EM, Wen D, Broze GJ Jr, Miletich JP, Flandermeyer RR, Siegel NR, Sadler JE. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 1987; 26: 5234-8.
30. Ruf W, Rehemtulla A, Edgington TS. Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J 1991; 278 (Pt 3): 729-33.
31. Huang M, Syed R, Stura EA, Stone MJ, Stefanko RS, Ruf W, Edgington TS, Wilson IA. The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J Mol Biol 1998; 275: 873-94.